# Tactical Review — 2026-08-10 U.S. Session

## Conclusion First

**WAIT / NO TRADE.** The read-only deterministic evaluator returned
`DAILY_REVIEW`, grade `E`, with no actionable holding-risk or watchlist
candidate. No order was placed or scheduled, no fill was inferred, and neither
portfolio state nor runtime/dedup state was changed.

## Session and Data Status

- Run timestamp: 2026-08-11 21:23 KST / 2026-08-11 08:23 ET.
- Latest completed U.S. regular session: 2026-08-10.
- Calendar: verified normal session; no early close, using the official
  [NYSE hours and calendars](https://www.nyse.com/markets/hours-calendars) and
  [2026 NYSE trading calendar](https://www.nyse.com/publicdocs/nyse/ICE_NYSE_2026_Yearly_Trading_Calendar.pdf).
- Market snapshot: completed regular-session bars only; yfinance was an
  unofficial sequential raw-data collector and critical closes received an
  independent completed-close cross-check.
- Verified brokerage cash read from state: USD 3,264.31. No cash was invented.

## Held Positions

### SOXL

- Direct SOXL and SOXX proxy closes passed validation.
- SOXL closed below its validated EMA10 and EMA20; SOXX was above EMA10 but
  below EMA20.
- The next weakness-reduction slot remains locked after the confirmed 24-share
  reduction because the required common-session EMA20 recovery/rearm condition
  has not occurred.
- The 10-EMA weakness condition is observation-only, not a standalone reduction.
- Deterministic result: no actionable quantity; hold/risk watch only.

### MVLL

- Direct MVLL close passed validation and MRVL provided corroboration only.
- The proxy was not used as a substitute for the MVLL close.
- No active hard-risk or staged-reduction trigger was present.
- Deterministic result: no actionable quantity; hold/risk watch only.

## Non-Held Tactical Candidates

- NBIS: validated close and technical data were available, but the price was
  below EMA10 and EMA20 and exact-instrument new-buy/sizing approval is absent.
- FSLY, RBRK, NET, NOW, MDB, DDOG, SNOW, CRWD, PANW, PLTR: watchlist inclusion
  is research-only. The current run did not have one same-cutoff primary-source
  identity, commercialization, fundamentals, valuation, and technical packet
  for these names.
- Short selling is not approved for any candidate.

## Two-Stage Candidate Result

- Stage 1 screened: all 13 approved research-watchlist names.
- Stage 1 shortlist: none.
- Stage 2 deep research: not run because no candidate cleared mandatory gates.
- Preferred candidate: none.
- Alternative candidate: none.

Not running maximum-depth research after a failed Stage 1 gate is intended
behavior, not a missing trade.

## Deterministic Gate

- State: `DAILY_REVIEW`.
- Grade: `E`.
- Result: `NO_ACTIONABLE_CANDIDATE`.
- Quantity: not authorized.
- External action: human-only and not requested.

## Reasons to Wait

1. No deterministic held-position risk trigger is active.
2. SOXL's next weakness slot is still locked by the rearm contract.
3. No non-held instrument has new-buy and quantity/risk approval.
4. Lane C lacks a common-cutoff verified research packet.
5. A new trade is not required merely because verified cash is positive.

## Next Review Trigger

Review again after a later completed regular session when either a deterministic
holding-risk trigger appears, or the user explicitly approves an exact new-buy
instrument and sizing/risk policy and the candidate passes evidence, thesis,
valuation, technical, liquidity, and portfolio-fit gates.

No decision-journal record was created because no candidate entered the deep
research/decision chain and no append-only production memory writer is approved.
